Trial Site Detail

 

Drug:
Imatinib
Trial:
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

University of Pittsburgh Cancer Institute

     
Pittsburgh , PA 15232
USA

 

Principal Investigator:
 Hussein Tawbi, MD
Contact:
 Julia Irwin, RN, BSN, OCN 412-623-4036 neelyja@upmc.edu
Activation Status of this Site:
 Closed
Notes about this Site:
University of Pittsburgh Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.